Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 208581
Company: ZYDUS PHARMS

Products on ANDA 208581

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
NYSTATIN	NYSTATIN	100,000 UNITS/GM	POWDER;TOPICAL	Prescription	AT	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 208581

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
06/08/2017	ORIG-1	Approval		STANDARD		Label is not available on this site.

Therapeutic Equivalents for ANDA 208581

NYSTATIN

POWDER;TOPICAL; 100,000 UNITS/GM
TE Code = AT

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
KLAYESTA	NYSTATIN	100,000 UNITS/GM	POWDER;TOPICAL	Prescription	No	AT	210532	EPIC PHARMA LLC
NYSTATIN	NYSTATIN	100,000 UNITS/GM	POWDER;TOPICAL	Prescription	No	AT	065203	DR REDDYS LABS SA
NYSTATIN	NYSTATIN	100,000 UNITS/GM	POWDER;TOPICAL	Prescription	No	AT	065138	LUPIN
NYSTATIN	NYSTATIN	100,000 UNITS/GM	POWDER;TOPICAL	Prescription	No	AT	208838	LYNE
NYSTATIN	NYSTATIN	100,000 UNITS/GM	POWDER;TOPICAL	Prescription	No	AT	065183	UPSHER SMITH LABS
NYSTATIN	NYSTATIN	100,000 UNITS/GM	POWDER;TOPICAL	Prescription	No	AT	208581	ZYDUS PHARMS
NYSTOP	NYSTATIN	100,000 UNITS/GM	POWDER;TOPICAL	Prescription	No	AT	064118	PADAGIS US